Tissue Engineering Models of Disease II

Track Chair(s)

• 

  Chelsea Magin, PhD

  Assistant Professor
  University of Colorado, Denver | Anschutz
  Aurora, Colorado, United States
• CK

  Cathal John Kearney

Session Chair(s)

• 

  Di Zhang, PhD

  Post-doctoral Associate
  Yale University
  New Haven, Connecticut, United States
• JH

  Jeongmin Hwang, PhD

  Post-doctoral Fellow
  Northwestern University, United States

Presentations:

• 8:30 AM - 8:45 AM PDT

  Investigating the Role of Lamins A/C in Maintaining Nuclear Stability Using a Novel 3D in vitro Model of Muscular Dystrophy
  

  Presenting Author: Anna Hazelwood – Cornell University

  Co-Author: Arne Hofemeier – University Medical Center Göttingen

  Co-Author: Timo Betz – University of Göttingen

  Primary Investigator: Jan Lammerding, PhD – Cornell University
• 8:45 AM - 9:00 AM PDT

  A vascularized midbrain-on-a-chip model for studying a-synuclein-induced vascular pathology in Parkinson's Disease.
  

  Presenting Author: Anika Alim – Binghamton University, SUNY

  Primary Investigator: Jungwook Paek – Binghamton University, SUNY
• 9:00 AM - 9:15 AM PDT

  Developing a Biofabricated Vascular Model to Study Endothelial Cell Roles in Breast Cancer Progression Following Cardiovascular Disease
  

  Presenting Author: Kira Lynch – Oregon Health & Science University

  Co-Author: Holly Day – Oregon Health and Science University

  Co-Author: Kevin Schilling, PhD – Oregon Health& Science University

  Co-Author: Monica Hinds – Oregon Health & Science University

  Primary Investigator: Carolyn Schutt, PhD – Oregon Health & Science University
• 9:15 AM - 9:30 AM PDT

  Modeling the synergistic effects of alcohol and fats on liver disease via engineered cocultures
  

  Presenting Author: Owen Lally, BS – University of Illinois Chicago

  Primary Investigator: Salman Khetani – University of Illinois Chicago
• 9:30 AM - 9:45 AM PDT

  Multi-physics 3D human brain models elucidate mechanical mechanisms in Alzheimer’s disease
  

  Presenting Author: Xun Wang, PhD – Massachusetts Institute of Technology & Massachusetts General Hospital

  Co-Author: Zhengyu Zhang – Massachusetts Institute of Technology

  Co-Author: Seunggyu Kim – Massachusetts Institute of Technology

  Co-Author: Maria Proestaki – Massachusetts Institute of Technology

  Co-Author: Annabel Tiong – Massachusetts Institute of Technology

  Co-Author: Zhengpeng Wan – Massachusetts Inst Technology - Cambridge, MA

  Co-Author: Rudolph Tanzi – Massachusetts General Hospital & Harvard Medical School

  Co-Author: Ming Guo – Massachusetts Institute of Technology

  Co-Author: Se Hoon Choi – Massachusetts General Hospital & Harvard Medical School

  Last Author: Roger Kamm – Massachusetts Institute of Technology

  Primary Investigator: Roger Kamm – Massachusetts Institute of Technology
• 9:45 AM - 10:00 AM PDT

  Evaluating In Vitro Cardiovascular Toxicity using Tissue-Engineered Blood Vessels (TEBVs)
  

  Presenting Author: Enmeng Xu, MS – Duke University

  Co-Author: Nicole C. Kleinstreuer – National Institutes of Health (NIH)

  Co-Author: Kelly Shipkowski, PhD, DABT – Division of Translational Toxicology, National Institute of Environmental Health Sciences

  Co-Author: Brandiese Beverly – Integrative Health Assessment Branch in the Division of Translational Toxicology (DTT) at NIEHS

  Co-Author: Shagun Krishna – Physicians Committee for Responsible Medicine (PCRM)

  Co-Author: David Gerhold, Ph.D. – NCATS, NIH Chemical Genomics Center Rockville

  Last Author: George Truskey – Duke University

  Primary Investigator: George Truskey – Duke University